Dual mechanisms by which miR-125b represses IRF4 to induce myeloid and B-cell leukemias

Blood

Volumn 124, Issue 9, 2014, Pages 1502-1512

  So, Alex Yick Lun ^a   Sookram, Reeshelle ^a   Chaudhuri, Aadel A ^a,b   Minisandram, Aarathi ^a   Cheng, David ^a   Xie, Catherine ^a   Lim, Ee Lyn ^a   Flores, Yvette Garcia ^a   Jiang, Shuai ^a   Kim, Jocelyn Tammy ^a   Keown, Christopher ^c   Ramakrishnan, Parameswaran ^d   Baltimore, David ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; INTERFERON REGULATORY FACTOR 4; MICRORNA 125B; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR-4; MESSENGER RNA; MICRORNA; MIRN125 MICRORNA, HUMAN; MIRN125 MICRORNA, MOUSE; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL LEUKEMIA; BONE MARROW CELL; CANCER CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL TRANSPLANTATION; COMPARATIVE GENOMIC HYBRIDIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; DENDRITIC CELL; GENE DELETION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GRANULOCYTE; HEMATOPOIETIC STEM CELL; LEUKEMIA CELL; MACROPHAGE; MOUSE; MYELOID LEUKEMIA; MYELOID PROGENITOR CELL; NONHUMAN; PRIORITY JOURNAL; SINGLE CELL ANALYSIS; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CANCER STEM CELL; CANCER TRANSPLANTATION; FEMALE; GENETICS; HUMAN; LEUKEMIA, B-CELL; LEUKEMIA, MYELOID; METABOLISM; PATHOLOGY;

ANIMALS; FEMALE; GENE DELETION; HEMATOPOIETIC STEM CELLS; HUMANS; INTERFERON REGULATORY FACTORS; LEUKEMIA, B-CELL; LEUKEMIA, MYELOID; MICE; MICE, INBRED C57BL; MICRORNAS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; RNA, MESSENGER; RNA, NEOPLASM; UP-REGULATION;

EID: 84907330294     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-02-553842     Document Type: Article

References (35)

1. Chapiro E, Russell LJ, Struski S, et al. A new recurrent translocation t(11;14)(q24;q32) involving IGH@ and miR-125b-1 in B-cell progenitor acute lymphoblastic leukemia. Leukemia. 2010;24(7): 1362-1364.
2. Tassano E, Acquila M, Tavella E, Micalizzi C, Panarello C, Morerio C. MicroRNA-125b-1 and BLID upregulation resulting from a novel IGH translocation in childhood B-Cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2010;49(8):682-687.
3. Zhang H, Luo XQ, Zhang P, et al. MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. PLoS ONE. 2009;4(11):e7826.
4. Bousquet M, Harris MH, Zhou B, Lodish HF. MicroRNA miR-125b causes leukemia. Proc Natl Acad Sci USA. 2010;107(50):21558-21563.
5. Chaudhuri AA, So AY, Mehta A, et al. Oncomir miR-125b regulates hematopoiesis by targeting the gene Lin28A. Proc Natl Acad Sci USA. 2012; 109(11):4233-4238.
6. Enomoto Y, Kitaura J, Hatakeyama K, et al. Em/miR-125b transgenic mice develop lethal B-cell malignancies. Leukemia. 2011;25(12):1849-1856.
7. O'Connell RM, Chaudhuri AA, Rao DS, Gibson WS, Balazs AB, Baltimore D. MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output. Proc Natl Acad Sci USA. 2010;107(32):14235-14240.
8. Chaudhuri AA, So AY, Sinha N, et al. MicroRNA-125b potentiates macrophage activation. J Immunol. 2011;187(10):5062-5068.
9. Ortmann CA, Burchert A, Hölzle K, et al. Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter region. Nucleic Acids Res. 2005;33(21): 6895-6905.
10. Schmidt M, Hochhaus A, König-Merediz SA, et al. Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapy. J Clin Oncol. 2000;18(19):3331-3338.
11. Klein F, Feldhahn N, Mooster JL, et al. Tracing the pre-B to immature B cell transition in human leukemia cells reveals a coordinated sequence of primary and secondary IGK gene rearrangement, IGK deletion, and IGL gene rearrangement. J Immunol. 2005;174(1):367-375.
12. Jo SH, Schatz JH, Acquaviva J, Singh H, Ren R. Cooperation between deficiencies of IRF-4 and IRF-8 promotes both myeloid and lymphoid tumorigenesis. Blood. 2010;116(15): 2759-2767.
13. Ma S, Shukla V, Fang L, Gould KA, Joshi SS, Lu R. Accelerated development of chronic lymphocytic leukemia in New Zealand Black mice expressing a low level of interferon regulatory factor 4. J Biol Chem. 2013;288(37): 26430-26440.
14. Shukla V, Ma S, Hardy RR, Joshi SS, Lu R. A role for IRF4 in the development of CLL. Blood. 2013; 122(16):2848-2855.
15. Bousquet M, Quelen C, Rosati R, et al. Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation. J Exp Med. 2008;205(11):2499-2506.
16. Kumar A, White TA, MacKenzie AP, et al. Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers. Proc Natl Acad Sci USA. 2011;108(41): 17087-17092.
17. Ley TJ, Mardis ER, Ding L, et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature. 2008;456(7218):66-72.
18. Lilljebj örn H, Rissler M, Lassen C, et al. Wholeexome sequencing of pediatric acute lymphoblastic leukemia. Leukemia. 2012;26(7):1602-1607.
19. Wang L, Lawrence MS, Wan Y, et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med. 2011;365(26):2497-2506.
20. Yoshida K, Sanada M, Shiraishi Y, et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature. 2011;478(7367):64-69.
21. Zhao JL, Rao DS, O'Connell RM, Garcia-Flores Y, Baltimore D. MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice. eLife. 2013; 2:e00537.
22. Kitamura D, Roes J, Kühn R, Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature. 1991;350(6317):423-426.
23. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. RAG-1-deficient mice have no mature B and T lymphocytes. Cell. 1992;68(5):869-877.
24. Gururajan M, Haga CL, Das S, et al. MicroRNA 125b inhibition of B cell differentiation in germinal centers. Int Immunol. 2010;22(7):583-592.
25. Malumbres R, Sarosiek KA, Cubedo E, et al. Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood. 2009;113(16):3754-3764.
26. Acquaviva J, Chen X, Ren R. IRF-4 functions as a tumor suppressor in early B-cell development. Blood. 2008;112(9):3798-3806.
27. Jo SH, Ren R. IRF-4 suppresses BCR/ABL transformation of myeloid cells in a DNA binding-independent manner. J Biol Chem. 2012;287(3):1770-1778.
28. Pathak S, Ma S, Trinh L, et al. IRF4 is a suppressor of c-Myc induced B cell leukemia. PLoS ONE. 2011;6(7):e22628.
29. Yamamoto M, Kato T, Hotta C, et al. Shared and distinct functions of the transcription factors IRF4 and IRF8 in myeloid cell development. PLoS ONE. 2011;6(10):e25812.
30. Guo S, Bai H, Megyola CM, et al. Complex oncogene dependence in microRNA-125a-induced myeloproliferative neoplasms. Proc Natl Acad Sci USA. 2012;109(41):16636-16641.
31. Sonoki T, Iwanaga E, Mitsuya H, Asou N. Insertion of microRNA-125b-1, a human homologue of lin-4, into a rearranged immunoglobulin heavy chain gene locus in a patient with precursor B-cell acute lymphoblastic leukemia. Leukemia. 2005; 19(11):2009-2010.
32. Di Bernardo MC, Crowther-Swanepoel D, Broderick P, et al. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat Genet. 2008;40(10): 1204-1210.
33. Lan Q, Au WY, Chanock S, et al. Genetic susceptibility for chronic lymphocytic leukemia among Chinese in Hong Kong. Eur J Haematol. 2010;85(6):492-495.
34. Slager SL, Goldin LR, Strom SS, et al. Genetic susceptibility variants for chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev. 2010;19(4): 1098-1102.
35. Havelange V, Pekarsky Y, Nakamura T, et al. IRF4 mutations in chronic lymphocytic leukemia. Blood. 2011;118(10): 2827-2829.